Research shows that the source of the lung lobe image is Global Look Press.
Scientists at the University of Ottawa have found that individuals who use marijuana have more signs of respiratory inflammation and lung emphysema in their lungs compared to smokers. This research was published in the Radiology journal.
Scientists analyzed the results of chest computed tomography (CT) scans from 56 cannabis users, 57 non-smokers, and 33 smokers. The data was obtained from October 2005 to July 2020 in Ottawa, Canada.
Compared to non-smokers, CT scans of marijuana users show differing frequencies of signs of respiratory inflammation, such as emphysema, bronchial thickening, bronchial dilation, mucous obstruction, and cardiac nodules.
Consumers of marijuana are 93% more likely to suffer from chronic obstructive pulmonary disease (COPD) compared to non-smokers, while smokers who consume marijuana have a 67% increased frequency of smoking.
A study has found that 38% of marijuana users who participated in the study reported experiencing gynecomastia, a condition that causes pathological breast enlargement in males. Of those affected, 16% were non-smokers.
This study has limitations, as it was not able to clearly distinguish the consequences of smoking from those of using marijuana. Firstly, only 28 out of 56 patients provided information about their daily marijuana intake, with an average of 1.85 grams per day.
Furthermore, out of 56 marijuana consumers, 50 of them also smoke. The author calls for further research.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS and we cannot confirm the authenticity or accuracy of its content. The translation of this article is solely intended for industry-related research and communication.
Due to limitations in translation ability, the translated article may not fully reflect the original content. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign positions and statements.
Information compiled here is the property of the original media and authors. If there is any infringement, please contact us to request removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
